Advertisement

pp 1-26 | Cite as

Chronic Chikungunya Virus Disease

  • Mary K. McCarthy
  • Bennett J. J. Davenport
  • Thomas E. MorrisonEmail author
Chapter
Part of the Current Topics in Microbiology and Immunology book series

Abstract

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has caused both small- and large-scale epidemics of incapacitating musculoskeletal disease across the globe. A substantial proportion of infected individuals experience debilitating arthralgia and/or arthritis that can persist in relapsing or continuous forms for months to years, an occurrence that appears independent of viral strain and outbreak location. Due to the lack of CHIKV-specific vaccine or therapeutics, treatment of chronic CHIKV disease is limited to supportive care. Although the epidemiologic and molecular mechanisms that dictate resolution or chronicity of CHIKV disease remain unclear, several risk factors and immunological responses have been implicated in the development of chronic CHIKV disease. Mounting evidence from animal models and limited case studies indicates that chronic disease is likely a result of induced autoimmunity and/or viral persistence in joint-associated tissue. Due to the global spread and explosive, often unpredictable nature of CHIKV epidemics, concerted efforts to obtain a more precise understanding of the development and maintenance of chronic CHIKV disease must be at the forefront of investigative endeavors.

Notes

Acknowledgements

This work was supported by Public Health Service grants R01 AI108725, R01 AI123348, and U19 AI109680 (to T. E. Morrison), F32 AI122463 (to M. K. McCarthy), and T32 AR007534 (to B. J. J. Davenport) from the National Institute of Allergy and Infectious Diseases.

References

  1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581.  https://doi.org/10.1002/art.27584CrossRefGoogle Scholar
  2. Blettery M, Brunier L, Polomat K, Moinet F, Deligny C, Arfi S, Jean-Baptiste G, De Bandt M (2016) Brief report: management of chronic post-chikungunya rheumatic disease: the Martinican experience: chronic post-chikungunya rheumatic disease. Arthritis Rheumatol 68:2817–2824.  https://doi.org/10.1002/art.39775CrossRefGoogle Scholar
  3. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F (2008) Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island. Clin Infect Dis 47:469–475.  https://doi.org/10.1086/590003CrossRefGoogle Scholar
  4. Bouquillard É, Combe B (2009) A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine 76:654–657.  https://doi.org/10.1016/j.jbspin.2009.08.005CrossRefGoogle Scholar
  5. Bouquillard E, Fianu A, Bangil M, Charlette N, Ribéra A, Michault A, Favier F, Simon F, Flipo R-M (2017) Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (Rhumatochik study). Joint Bone Spine.  https://doi.org/10.1016/j.jbspin.2017.01.014Google Scholar
  6. Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection. A retrospective study of 107 cases. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 63:313–315Google Scholar
  7. Carey DE (1971) Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci 26:243–262Google Scholar
  8. Carey DE, Myers RM, DeRanitz CM, Jadhav M, Reuben R (1969) The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans R Soc Trop Med Hyg 63:434–445Google Scholar
  9. Chopra A, Anuradha V, Ghorpade R, Saluja M (2012) Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 140:842–850. https://doi.org/10.1017/S0950268811001300Google Scholar
  10. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M (2008) Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 58:2921–2922.  https://doi.org/10.1002/art.23753CrossRefGoogle Scholar
  11. Chopra A, Saluja M, Venugopalan A (2014) Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 66:319–326.  https://doi.org/10.1002/art.38221CrossRefGoogle Scholar
  12. Chow A, Her Z, Ong EKS, Chen J, Dimatatac F, Kwek DJC, Barkham T, Yang H, Rénia L, Leo Y-S, Ng LFP (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157.  https://doi.org/10.1093/infdis/jiq042CrossRefGoogle Scholar
  13. Couturier E, Guillemin F, Mura M, Léon L, Virion J-M, Letort M-J, De Valk H, Simon F, Vaillant V (2012) Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology 51:1315–1322.  https://doi.org/10.1093/rheumatology/kes015CrossRefGoogle Scholar
  14. De Ranitz CM, Myers RM, Varkey MJ, Isaac ZH, Carey DE (1965) Clinical impressions of chikungunya in Vellore gained from study of adult patients. Indian J Med Res 53:756–763Google Scholar
  15. Dougados M, Linden SVD, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H (1991) The European spondyloarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227.  https://doi.org/10.1002/art.1780341003CrossRefGoogle Scholar
  16. Elsinga J, Gerstenbluth I, van der Ploeg S, Halabi Y, Lourents NT, Burgerhof JG, van der Veen HT, Bailey A, Grobusch MP, Tami A (2017) Long-term Chikungunya Sequelae in Curaçao: Burden, Determinants, and a Novel Classification Tool. J Infect Dis 216:573–581. https://doi.org/10.1093/infdis/jix312Google Scholar
  17. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K (2013) Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J 89:440–447.  https://doi.org/10.1136/postgradmedj-2012-131477CrossRefGoogle Scholar
  18. Feldstein LR, Rowhani-Rahbar A, Staples JE, Weaver MR, Halloran ME, Ellis EM (2017) Persistent arthralgia associated with chikungunya virus outbreak, US Virgin Islands, December 2014–February 2016. Emerg Infect Dis 23:673–676.  https://doi.org/10.3201/eid2304.161562CrossRefGoogle Scholar
  19. Foissac M, Javelle E, Ray S, Guerin B, Simon F (2015) Post-chikungunya rheumatoid arthritis, saint martin. Emerg Infect Dis 21:530–532.  https://doi.org/10.3201/eid2103.141397CrossRefGoogle Scholar
  20. Fourie ED, Morrison JG (1979) Rheumatoid arthritic syndrome after chikungunya fever. South Afr Med J 56:130–132Google Scholar
  21. Ganu MA, Ganu AS (2011) Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up. J Assoc Physicians India 59:83–86Google Scholar
  22. Gear J, Reid FP (1957) The occurrence of a dengue-like fever in the North-Eastern Transvaal. I. Clinical features and isolation of virus. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 31:253–257Google Scholar
  23. Gérardin P, Fianu A, Malvy D, Mussard C, Boussaïd K, Rollot O, Michault A, Gaüzere B-A, Bréart G, Favier F (2011) Perceived morbidity and community burden after a chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med 9:5.  https://doi.org/10.1186/1741-7015-9-5CrossRefGoogle Scholar
  24. Gérardin P, Fianu A, Michault A, Mussard C, Boussaïd K, Rollot O, Grivard P, Kassab S, Bouquillard E, Borgherini G, Gaüzère B-A, Malvy D, Bréart G, Favier F (2013) Predictors of chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther 15:R9.  https://doi.org/10.1186/ar4137CrossRefGoogle Scholar
  25. Grandadam M, Caro V, Plumet S, Thiberge J-M, Souarès Y, Failloux A-B, Tolou HJ, Budelot M, Cosserat D, Leparc-Goffart I, Desprès P (2011) Chikungunya virus, Southeastern France. Emerg Infect Dis 17:910–913.  https://doi.org/10.3201/eid1705.101873CrossRefGoogle Scholar
  26. Halstead SB, Scanlon JE, Umpaivit P, Udomsakdi S (1969a) Dengue and chikungunya virus infection in man in Thailand, 1962–1964. IV. Epidemiologic studies in the Bangkok Metropolitan area. Am J Trop Med Hyg 18:997–1021.  https://doi.org/10.4269/ajtmh.1969.18.997CrossRefGoogle Scholar
  27. Halstead SB, Udomsakdi S, Scanlon JE, Rohitayodhin S (1969b) Dengue and chikungunya virus infection in man in Thailand, 1962–1964. V. Epidemiologic observations outside Bangkok. Am J Trop Med Hyg 18:1022–1033.  https://doi.org/10.4269/ajtmh.1969.18.1022CrossRefGoogle Scholar
  28. Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888.  https://doi.org/10.1128/JVI.02666-13CrossRefGoogle Scholar
  29. Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KMS, Torres RM, Crowe JE Jr, Dermody TS, Diamond MS, Morrison TE (2016) Pathogenic chikungunya virus evades B cell Responses to establish persistence. Cell Rep 16:1326–1338.  https://doi.org/10.1016/j.celrep.2016.06.076CrossRefGoogle Scholar
  30. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P (2010) Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184:5914–5927.  https://doi.org/10.4049/jimmunol.0900255CrossRefGoogle Scholar
  31. Hoarau J-J, Gay F, Pellé O, Samri A, Jaffar-Bandjee M-C, Gasque P, Autran B (2013) Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005–2006 in La Reunion Island. PLoS ONE 8:e84695Google Scholar
  32. Javelle E, Ribera A, Degasne I, Gaüzère B-A, Marimoutou C, Simon F (2015) Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006–2012. PLoS Negl Trop Dis 9:e0003603.  https://doi.org/10.1371/journal.pntd.0003603CrossRefGoogle Scholar
  33. Kam Y-W, Simarmata D, Chow A, Her Z, Teng T-S, Ong EKS, Rénia L, Leo Y-S, Ng LFP (2012) Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis 205:1147–1154.  https://doi.org/10.1093/infdis/jis033CrossRefGoogle Scholar
  34. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S (2011) Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5:e1279.  https://doi.org/10.1371/journal.pntd.0001279CrossRefGoogle Scholar
  35. Kennedy AC, Fleming J, Solomon L (1980) Chikungunya viral arthropathy: a clinical description. J Rheumatol 7:231–236Google Scholar
  36. Kularatne SAM, Weerasinghe SC, Gihan C, Wickramasinghe S, Dharmarathne S, Abeyrathna A, Jayalath T (2012) Epidemiology, Clinical Manifestations, and Long-Term Outcomes of a Major Outbreak of Chikungunya in a Hamlet in Sri Lanka, in 2007: A Longitudinal Cohort Study. J Trop Med 2012:1–6. https://doi.org/10.1155/2012/639178Google Scholar
  37. Kulkarni SP, Ganu M, Jayawant P, Thanapati S, Ganu A, Tripathy AS (2017) Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study. Eur J Clin Microbiol Infect Dis, 1–7.  https://doi.org/10.1007/s10096-017-3087-4Google Scholar
  38. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120:894–906.  https://doi.org/10.1172/JCI40104CrossRefGoogle Scholar
  39. Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur M-C, Sissoko D, Ezzedine K, Malvy D (2010) Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 47:85–88.  https://doi.org/10.1016/j.jcv.2009.11.014CrossRefGoogle Scholar
  40. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X (2014) Chikungunya in the Americas. The Lancet 383:514.  https://doi.org/10.1016/S0140-6736(14)60185-9CrossRefGoogle Scholar
  41. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399.  https://doi.org/10.1016/j.trstmh.2010.01.011CrossRefGoogle Scholar
  42. Marimoutou C, Ferraro J, Javelle E, Deparis X, Simon F (2015) Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later. Clin Microbiol Infect 21:688–693.  https://doi.org/10.1016/j.cmi.2015.02.024CrossRefGoogle Scholar
  43. Marimoutou C, Vivier E, Oliver M, Boutin J-P, Simon F (2012) Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection: Comparative Cohort of Infected and Uninfected French Military Policemen in Reunion Island. Medicine 91:212–219. https://doi.org/10.1097/MD
  44. Marques CDL, Duarte ALBP, Ranzolin A, Dantas AT, Cavalcanti NG, Gonçalves RSG, Junior LF da R, Valadares LD de A, Melo AKG de, Freire EAM, Teixeira R, Neto FAB, Medeiros MM das C, Carvalho JF de, Santos MSF, Océa RA de LC, Levy RA, Andrade CAF de, Pinheiro G da RC, Abreu MM, Verztman JF, Merenlender S, Ribeiro SLE, Costa IP da, Pileggi G, Trevisani VFM, Lopes MIB, Brito C, Figueiredo E, Queiroga F, Feitosa T, Tenório A da S, Siqueira GR de, Paiva R, Vasconcelos JTS, Christopoulos G (2017) Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2—Treatment. Rev Bras Reumatol Engl Ed.  https://doi.org/10.1016/j.rbre.2017.06.004Google Scholar
  45. Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, Chopra A, On behalf of the Trivandrum COPCORD Study Group (2011) Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract 65:1306–1312.  https://doi.org/10.1111/j.1742-1241.2011.02792.xGoogle Scholar
  46. McCarthy MK, Morrison TE (2017) Persistent RNA virus infections: do PAMPS drive chronic disease? Curr Opin Virol 23:8–15.  https://doi.org/10.1016/j.coviro.2017.01.003CrossRefGoogle Scholar
  47. Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, DeFilippis VR, Streblow DN (2013) Chikungunya virus infection results in higher and persistent viral replication in aged Rhesus macaques due to defects in anti-viral immunity. PLoS Negl Trop Dis 7:e2343.  https://doi.org/10.1371/journal.pntd.0002343CrossRefGoogle Scholar
  48. Miner JJ, Aw Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, Kim AHJ, Diamond MS, Lenschow DJ, Yokoyama WM (2015) Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 67:1214–1220.  https://doi.org/10.1002/art.39027CrossRefGoogle Scholar
  49. Mogami R, de Almeida Vieira A, Junqueira Filho EA, Lopes AJ (2017a) Chikungunya fever outbreak in Rio de Janeiro, Brazil: ultrasonographic aspects of musculoskeletal complications. J Clin Ultrasound 45:43–44.  https://doi.org/10.1002/jcu.22394CrossRefGoogle Scholar
  50. Mogami R, Pereira Vaz JL, de Fátima Barcelos Chagas Y, de Abreu MM, Torezani RS, de Almeida Vieira A, Junqueira Filho EA, Barbosa YB, Carvalho ACP, Lopes AJ (2017b) Ultrasonography of hands and wrists in the diagnosis of complications of chikungunya fever. J Ultrasound Med.  https://doi.org/10.1002/jum.14344Google Scholar
  51. Mogami R, Vaz JLP, Chagas Y de FB, Torezani RS, Vieira A de A, Koifman ACB, Barbosa YB, de Abreu MM (2017c) Ultrasound of ankles in the diagnosis of complications of chikungunya fever. Radiol Bras 50:71–75.  https://doi.org/10.1590/0100-3984.2016.0221Google Scholar
  52. Moore DL, Reddy S, Akinkugbe FM, Lee VH, David-West TS, Causey OR, Carey DE (1974) An epidemic of chikungunya fever at Ibadan, Nigeria, 1969. Ann Trop Med Parasitol 68:59–68Google Scholar
  53. Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P (2010) Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg 82:508–511.  https://doi.org/10.4269/ajtmh.2010.09-0322CrossRefGoogle Scholar
  54. Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, Miserocchi F, Sambo P, Finarelli AC, Sambri V, Gagliotti C, Massimiliani E, Mattivi A, Pierro AM, Macini P (2012) Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect 65:165–172.  https://doi.org/10.1016/j.jinf.2012.04.005CrossRefGoogle Scholar
  55. Murillo-Zamora E, Mendoza-Cano O, Trujillo-Hernández B, Alberto Sánchez-Piña R, Guzmán-Esquivel J (2017) Persistent arthralgia and related risks factors in laboratory-confirmed cases of chikungunya virus infection in Mexico. Rev Panam Salud Pública 41Google Scholar
  56. Muyembe-Tamfum JJ, Peyrefitte CN, Yogolelo R, Mathina Basisya E, Koyange D, Pukuta E, Mashako M, Tolou H, Durand JP (2003) Epidemic of chikungunya virus in 1999 and 200 in the democratic republic of the Congo. Med Trop Rev Corps Sante Colon 63:637–638Google Scholar
  57. Myers RM, Carey DE, Reuben R, Jesudass ES, De Ranitz C, Jadhav M (1965) The 1964 epidemic of dengue-like fever in South India: isolation of chikungunya virus from human sera and from mosquitoes. Indian J Med Res 53:694–701Google Scholar
  58. Nakaya HI, Gardner J, Poo Y-S, Major L, Pulendran B, Suhrbier A (2012) Gene profiling of chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum 64:3553–3563.  https://doi.org/10.1002/art.34631CrossRefGoogle Scholar
  59. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97:1920–1924.  https://doi.org/10.1182/blood.V97.7.1920CrossRefGoogle Scholar
  60. Ozden S, Huerre M, Riviere J-P, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger J-C, Amrani ME, Yvin J-L, Jaffar M-C, Frenkiel M-P, Sourisseau M, Schwartz O, Butler-Browne G, Desprès P, Gessain A, Ceccaldi P-E (2007) Human muscle satellite cells as targets of chikungunya virus infection. PLoS ONE 2:e527.  https://doi.org/10.1371/journal.pone.0000527CrossRefGoogle Scholar
  61. Petersen LR, Powers AM (2016) Chikungunya: epidemiology. F1000Research.  https://doi.org/10.12688/f1000research.7171.1
  62. Poo YS, Rudd PA, Gardner J, Wilson JAC, Larcher T, Colle M-A, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A (2014) Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl Trop Dis 8:e3354.  https://doi.org/10.1371/journal.pntd.0003354CrossRefGoogle Scholar
  63. Powers AM, Logue CH (2007) Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88:2363–2377.  https://doi.org/10.1099/vir.0.82858-0CrossRefGoogle Scholar
  64. Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444.  https://doi.org/10.3899/jrheum.141609CrossRefGoogle Scholar
  65. Ramachandran V, Kaur P, Kanagasabai K, Vadivoo S, Murhekar MV (2014) Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai, South India. J Postgrad Med 60:3. https://doi.org/10.4103/0022-3859.128795Google Scholar
  66. Ravi V (2006) Re-emergence of chikungunya virus in India. Indian J Med Microbiol, 83–84Google Scholar
  67. Ravindran V, Alias G (2017) Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 36:1335–1340.  https://doi.org/10.1007/s10067-016-3429-0CrossRefGoogle Scholar
  68. Renault P, Solet J-L, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, de Valk H et al (2007) A major epidemic of chikungunya virus infection on Reunion Island, France, 2005–2006. Am J Trop Med Hyg 77:727–731Google Scholar
  69. Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. I. Clinical features. Trans R Soc Trop Med Hyg 49:28–32.  https://doi.org/10.1016/0035-9203(55)90080-8CrossRefGoogle Scholar
  70. Rodriguez-Morales AJ, Restrepo-Posada VM, Acevedo-Escalante N, Rodríguez-Muñoz ED, Valencia-Marín M, Castrillón-Spitia JD, Londoño JJ, Bedoya-Rendón HD, Cárdenas-Pérez J de J, Cardona-Ospina JA, Lagos-Grisales GJ (2017) Impaired quality of life after chikungunya virus infection: a 12-month follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia. Rheumatol Int, 1–2.  https://doi.org/10.1007/s00296-017-3795-1Google Scholar
  71. Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J (2016a) Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis: chronic inflammatory rheumatism following chikungunya. Arthritis Care Res 68:1849–1858.  https://doi.org/10.1002/acr.22900CrossRefGoogle Scholar
  72. Rodríguez-Morales AJ, Villamil-Gomez W, Merlano-Espinosa M, Simone-Kleber L (2016b) Post-chikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia. Clin Rheumatol 35:831–832.  https://doi.org/10.1007/s10067-015-3041-8CrossRefGoogle Scholar
  73. Ross RW (1956) The Newala epidemic. III. The virus: Isolation, Pathogenic Properties and Relationship to the Epidemic. J Hyg (Lond) 54:177–191Google Scholar
  74. Saluzzo JF, Cornet M, Digoutte JP (1983) Outbreak of a chikungunya virus epidemic in western Senegal in 1982. Dakar Med 28:497–500Google Scholar
  75. Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7:e2137.  https://doi.org/10.1371/journal.pntd.0002137CrossRefGoogle Scholar
  76. Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumilla AM, Konde J, Njenga MK, Sang R, Breiman RF (2008) Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 78:333–337Google Scholar
  77. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V (2007) Seroprevalence of chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg 76:1189–1193Google Scholar
  78. Shah KV, Gibbs CJ, Banerjee G (1964) Virological investigation of the epidemic of haemorrhagic fever in Calcutta: isolation of three strains of chikungunya virus. Indian J Med Res 52:676–683Google Scholar
  79. Shegarfi H, Naddafi F, Mirshafiey A (2012) Natural killer cells and their role in rheumatoid arthritis: friend or foe? Sci World J 2012:1–10.  https://doi.org/10.1100/2012/491974CrossRefGoogle Scholar
  80. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Mohamed AA, de Lamballerie X et al (2007) Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86:123–137Google Scholar
  81. Simon F, Javelle E, Cabie A, Bouquillard E, Troisgros O, Gentile G, Leparc-Goffart I, Hoen B, Gandjbakhch F, Rene-Corail P, Franco J-M, Caumes E, Combe B, Poiraudeau S, Gane-Troplent F, Djossou F, Schaerverbeke T, Criquet-Hayot A, Carrere P, Malvy D, Gaillard P, Wendling D (2015) French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Médecine Mal Infect 45:243–263.  https://doi.org/10.1016/j.medmal.2015.05.007CrossRefGoogle Scholar
  82. Sissoko D, Malvy D, Giry C, Delmas G, Paquet C, Gabrie P, Pettinelli F, Sanquer MA, Pierre V (2008) Outbreak of chikungunya fever in Mayotte, Comoros archipelago, 2005–2006. Trans R Soc Trop Med Hyg 102:780–786.  https://doi.org/10.1016/j.trstmh.2008.02.018CrossRefGoogle Scholar
  83. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V (2009) Post-epidemic chikungunya disease on Reunion Island: course of Rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3:e389.  https://doi.org/10.1371/journal.pntd.0000389CrossRefGoogle Scholar
  84. Staikowsky F, Roux KL, Schuffenecker I, Laurent P, Grivard P, Develay A, Michault A (2008) Retrospective survey of chikungunya disease in Réunion Island hospital staff. Epidemiol Amp Infect 136:196–206.  https://doi.org/10.1017/S0950268807008424CrossRefGoogle Scholar
  85. Teo T-H, Lum F-M, Claser C, Lulla V, Lulla A, Merits A, Renia L, Ng LFP (2013) A Pathogenic Role for CD4+ T Cells during chikungunya virus infection in mice. J Immunol 190:259–269.  https://doi.org/10.4049/jimmunol.1202177CrossRefGoogle Scholar
  86. Thanapati S, Ganu M, Giri P, Kulkarni S, Sharma M, Babar P, Ganu A, Tripathy AS (2017) Impaired NK cell functionality and increased TNF-α production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis. Hum Immunol 78:370–374.  https://doi.org/10.1016/j.humimm.2017.02.006CrossRefGoogle Scholar
  87. Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, de Lamballerie X (2013) Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 99:345–370.  https://doi.org/10.1016/j.antiviral.2013.06.009CrossRefGoogle Scholar
  88. Tomori O, Fagbami A, Fabiyi A (1975) The 1974 epidemic of chikungunya fever in children in Ibadan. Trop Geogr Med 27:413–417Google Scholar
  89. Uhrlaub JL, Pulko V, DeFilippis VR, Broeckel R, Streblow DN, Coleman GD, Park BS, Lindo JF, Vickers I, Anzinger JJ, Nikolich-Žugich J (2016) Dysregulated TGF-β production underlies the age-related vulnerability to chikungunya virus. PLoS Pathog 12:e1005891.  https://doi.org/10.1371/journal.ppat.1005891CrossRefGoogle Scholar
  90. van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP (2017) Long-term sequelae of chikungunya virus disease: a systematic review. Travel Med Infect Dis 15:8–22.  https://doi.org/10.1016/j.tmaid.2017.01.004CrossRefGoogle Scholar
  91. Venugopalan A, Ghorpade RP, Chopra A (2014) Cytokines in acute chikungunya. PLOS ONE 9:e111305.  https://doi.org/10.1371/journal.pone.0111305CrossRefGoogle Scholar
  92. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM (2011) The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204:115–123.  https://doi.org/10.1093/infdis/jiq006CrossRefGoogle Scholar
  93. Waymouth HE, Zoutman DE, Towheed TE (2013) Chikungunya-related arthritis: case report and review of the literature. Semin Arthritis Rheum 43:273–278.  https://doi.org/10.1016/j.semarthrit.2013.03.003CrossRefGoogle Scholar
  94. Win MK, Chow A, Dimatatac F, Go CJ, Leo YS (2010) Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 49:111–114.  https://doi.org/10.1016/j.jcv.2010.07.004CrossRefGoogle Scholar
  95. Yaseen HM, Simon F, Deparis X, Marimoutou C (2014) Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord 15:249.  https://doi.org/10.1186/1471-2474-15-249CrossRefGoogle Scholar
  96. Zim MA, Sam I-C, Omar SFS, Chan YF, AbuBakar S, Kamarulzaman A (2013) Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 56:141–145.  https://doi.org/10.1016/j.jcv.2012.10.019CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Mary K. McCarthy
    • 1
  • Bennett J. J. Davenport
    • 1
  • Thomas E. Morrison
    • 1
    Email author
  1. 1.Department of Immunology and MicrobiologyUniversity of Colorado School of MedicineAuroraUSA

Personalised recommendations